Latest Leverage News

Sports Entertainment Group (SEG) has upgraded its FY26 Underlying EBITDA guidance to a range of $15.5 million to $16.5 million, reflecting broad-based growth and operational efficiencies across its media and events businesses.

Connected Minerals (ASX:CML) is set to acquire Frontier Group CRM, gaining control of an 80% interest in the Bailundo carbonatite project in Angola, boasting near-surface high-grade niobium and rare earth mineralisation. Backed by a $4.5 million capital raise, the company aims to fast-track exploration in this emerging critical minerals jurisdiction.

Murray Cod Australia (ASX:MCA) is raising $18.6 million through a fully underwritten entitlement offer at a steep 43% discount to last price, aiming to convert its record 3,700-tonne biomass into sales and expand processing capacity.

Cosmo Metals has locked in a diamond drill rig to advance its high-impact program at the Kanowna Gold Project, targeting deep gold mineralisation near the Fitzroy Fault with government co-funding.

Merino & Co. has secured a three-year exclusive distribution agreement in Mainland China, guaranteeing a minimum annual order of CNY 30 million (~AUD 6.5 million) and targeting 20% yearly growth upon renewal.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

Arovella Therapeutics undergoes a major board overhaul and CEO resignation following a shareholder push, as the company embarks on a strategic review of its cell therapy platform.

Legacy Minerals reveals a robust 19-year Mt Carrington gold-silver project with a pre-tax NPV of A$716 million and low operating costs, advancing towards pre-feasibility studies amid resource conversion plans.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Navigator Global Investments (ASX: NGI) is acquiring a US$195 million portfolio of Net Revenue Share interests from Stable Asset Management, broadening its alternative asset manager ecosystem and raising A$145 million via a fully underwritten entitlement offer.

PYC Therapeutics presented Phase 1/2 data at ARVO 2026 showing encouraging safety and efficacy signals for its RNA therapies targeting rare genetic eye diseases Retinitis Pigmentosa type 11 and Autosomal Dominant Optic Atrophy.

SSH Group Ltd is set to acquire Elphinstone Mechanical Services, boosting its revenue scale and geographic reach into Queensland and New South Wales with an immediately accretive deal.